Virginia Commonwealth University (VCU) Health launched the Adult Sickle Cell Medical Home Program in 2018 to address a sharp rise in readmission rates and ED visits for patients with Sickle Cell Disease (SCD).1 This program delivers specialized, comprehensive treatment to almost 1,200 adult patients with SCD out of the total 5,000 patients across Virginia, marking a substantial growth in the patient population since the program’s inception. The program’s ‘inescapable’ structure ensures continuity in care and consistency in patient engagement, leaving little chance for patients to fall through the cracks in their transition from inpatient to outpatient care.2 Through their work, VCU improved trust in the healthcare system and significantly reduced overall costs of care for SCD patients.
SCD readmissions data from VCU Health revealed concerning trends: the 30-day readmission rate for patients with SCD had spiked to 33.7% in 2016, up from 22.5% just two years earlier.3 The average length of stay had increased by 2.5 days, and the number of emergency department (ED) visits was projected to double in 2017. VCU wanted to find a way to address the root causes of frequent ED visits among their patients with SCD, such as missed follow-up appointments, lack of provider expertise in SCD, funding challenges, and historic mistrust between patients and providers.
VCU Health is the medical campus of Virginia Commonwealth University, located in Richmond, VA. Under the direction of Dr. Wally Smith and Senior Program Manager Shirley Johnson, the Adult Sickle Cell Medical Home Program launched in 2018 to provide inpatient and outpatient treatment, research, and support for almost 1,200 adult patients with SCD out of the total 5,000 patients across Virginia.1 The program is comprised of a 20-person care team that focuses on identifying and overcoming barriers to healthcare access for patients with SCD.
An analysis of National Hospital Ambulatory Medical Care Survey (NHAMCS) data for the years 1999 to 2007 revealed that patients with SCD nationwide commonly experienced a persistent cycle of ED reliance and prolonged hospital stays, prompting VCU Health to develop the specialized Medical Home to break this cycle by offering accessible and comprehensive care.4 Led by SCD specialists and targeting the 50 highest utilizers based on the Centers for Medicare & Medicaid Services (CMS) guidelines, this initiative features a team-based approach with community health workers offering weekly individualized care management.5 The Medical Home integrates primary care with structured protocols for acute care and pain management, all coordinated within a collaborative care framework. VCU Health’s strategy aims to tackle the root causes of frequent ED visits and enhance the overall continuity and quality of care for patients with SCD, thus ensuring patient engagement with an “inescapable” program and improving long-term health outcomes.
VCU Health's specialized medical home approach for patients with SCD has yielded significant improvements across fiscal year 2019, with a 10% reduction in readmission rates and a decrease of 1,096 inpatient days across the 50 highest utilizers in VCU’s SCD population.6 Additionally, the “inescapable” program has effectively lowered the average hospital stay by 0.86 days and reduced no-show rates, reflecting an enhanced trust between patients and the healthcare system. Moreover, the program averted $2.465 million in charges for its highest utilizers over two years.
Initially, ED and inpatient providers were skeptical about the need for integrating specialized SCD care into their routine practices. In response, the VCU team compiled a compelling case using hospital admissions data to show SCD as a top reason for hospitalizations and emphasized the potential financial benefits of a specialized care program. Drawing from evidence from other chronic conditions, they showcased how targeted SCD care could lead to lower readmission rates and healthcare costs.
Identifying early advocates, including Dr. Smith, within the healthcare system’s leadership proved instrumental in securing the buy-in needed to drive the program forward with the right momentum and resources. Involving these key advocates and stakeholders from the outset ensures alignment of goals, a clear understanding of the initiative, and fosters a sense of ownership that leads to active program promotion.
VCU launched a pilot program targeting the highest ED utilizers among patients with SCD, a decision dictated by both strategy and the constraints of limited funding and resources. The program's design, which focused on potential for significant health outcomes and cost savings, demonstrated cost savings of $333,000 in patient care costs over six months.6
Encouraged by these results, VCU invested $1 million to broaden the program's scope to include 50 additional high-utilization patients. Capitalizing on the pilot program's momentum, VCU expanded its reach, demonstrating that a larger patient base could benefit even more from the program's approach.
The program’s success began to attract national attention, bolstering its case for further support. Through workshops with the American Society for Hematology, along with other advocacy efforts, the program influenced broader educational initiatives and became a benchmark for data-driven healthcare improvement. By 2024, the continued expansion of VCU’s Adult Sickle Cell Medical Home Program affirmed its ongoing dedication to enhancing the quality of care for patients with SCD.
VCU’s Adult Sickle Cell Medical Home Program is grounded in three fundamental components: create trusting patient-provider relationships to ensure patient engagement, center a community health worker in the core leadership team, and establish SCD-specific standardized care protocols and order sets for adult patients in the electronic health record (EHR). These strategies were integral in improving the inpatient to outpatient transition of care for patients with SCD.
Recognizing the importance of trust in effectively managing the transition from inpatient to outpatient care, VCU matched the 50 highest utilizer patients with a patient navigator. This provided a consistent point of contact, offering stability and informed support throughout the patient's healthcare journey, from initial hospitalization to continuous outpatient care. These patient navigators established strong, trusting relationships by personally connecting with patients. For example, navigators have taken patients grocery and clothing shopping, invited them over for Saturday tea, and even responded to phone calls of patients at 3 a.m. on their way to the ED.1,7
VCU also helped patients create adaptable treatment plans to address their changing health requirements. These plans went beyond medication and confronted any potential obstacles to care, including social drivers, memory issues, or the need for regular reminders. Involving patients in the decision-making process boosted their sense of autonomy and confidence in managing their disease. Additionally, VCU provided supportive resources, such as monthly support groups, which created a caring environment where patients could share their experiences and find encouragement.
VCU’s program is grounded in a biopsychosocial model of care, which considers the biological, psychological, and social factors essential to patient health.1,7 The key to its success is the formation of a care delivery team solely dedicated to patients with SCD, led by a program manager trained in social work.
In addition to a program manager, the care delivery team includes nurse practitioners, clinical social workers, and patient navigators who serve as primary points of contact for patients. Together, they provide comprehensive case management and coordinate closely with SCD providers to deliver holistic care. Meanwhile, an oversight team led by the senior program manager oversees the program's operations, focusing on smooth execution and enhancements through quality improvement initiatives, patient assessments, and analyses of data-driven outcomes.
* See endnote 8
VCU developed standardized protocols for SCD management to provide consistency, quality, and safety across the entire care continuum. First, VCU identified areas for improvement. After examining established guidelines and expert recommendations, they identified and addressed gaps in their care model, including discharge planning. They shifted towards reliable resources and created an inpatient care protocol based on their findings, moving away from inconsistent patient assistance programs and support groups.
One of the pivotal elements of their inpatient care protocol is the inclusion of in-hospital consultations by a SCD nurse practitioner. This step was crucial, as SCD management is often in the hands of hospitalists, who may lack SCD training. Ensuring follow-up after hospital discharge was also a significant concern, as a lack of coordination often resulted in patients returning to the ED due to medication issues.
VCU also constructed a suite of order sets and treatment protocols tailored to various stages of the patient's journey, from the ED through to ongoing follow-ups after discharge. For example, they standardized their approach to pain management to include having a single opioid prescriber to maintain controlled medication management for patients. These protocols are categorized based on specific patient needs, such as whether the patient is new, requires an annual exam, is transitioning into adult care, or is considered a high utilizer of services.
In 2019, VCU’s Adult Sickle Cell Medical Home Program made remarkable strides in enhancing patient care and efficiency, leading to a notable 10% reduction in patient readmission rates.6 This improvement not only reflects better quality of care but also contributes to significant cost savings, as proven by the program averting $2.465 million in charges during that same period.
The positive outcomes extended to the entire SCD patient population at VCU, with a substantial decrease of 1,096 inpatient days recorded in 2019. Additionally, the average hospital stay for patients with SCD was shortened by 0.86 days, indicating more efficient and effective patient care and management.
Patient engagement also improved, with the no-show rates dropping from 11% in 2019 to 6.8% in 2021.7 This decrease in no-shows is indicative of a more trusting relationship between patients and the healthcare team. “For many of these patients, they have a trusting relationship with members of our team,” said Shirley Johnson, VCU’s program manager.1 “They might not always like us, but they still trust us and they know that wherever they are, we will come and find them so they don’t fall through the cracks.”
“For many of these patients, they have a trusting relationship with members of our team.”
Since its inception, the SCD program at VCU has played a pivotal role in standing up 50 adult sickle cell centers across the United States.1 The program at VCU contributes extensively to the annual four-day Sickle Cell Care Coordination for Achieving Patient Empowerment (SCCAPE) Conference, which has been held since 2019.7 The conference’s mission is to train professionals and family advocates in comprehensive assessment, care coordination, medical management, and patient-centered treatment adherence for SCD. To learn more about SCCAPE, please visit www.sccape.org.
In addition to training these 50 SCD programs, VCU consistently receives weekly inquiries for additional training and support materials. These requests underscore the critical need for continued investment in the educational development and support for SCD providers.
Looking forward, VCU is strategically positioning itself to engage with national collaboratives, with the aim of sharing and analyzing data in tandem with other leading adult SCD medical home programs throughout the nation.7 This collaboration will allow VCU to benchmark and integrate best practices, optimizing care for SCD patients. Additionally, the quality improvement specialist at VCU has crafted surveys to capture patient experiences with their Sickle Cell Medical Home, specifically focusing on patient navigation, counseling services, and the prior authorization department. These surveys contribute to a deliberate effort to collect patient feedback and actively tackle care gaps. The team has also introduced a new metric to assess patient behavioral outcomes following navigation and community health worker interventions. This ongoing commitment to quality improvement underscores VCU’s dedication to advancing the standard of care for patients with SCD.
1 Note: Unless otherwise specified, all information in this case study came from Advisory Board interviews with contacts from VCU Health.
2 Note: SCD patients require care from a dedicated SCD provider and, as a result, the care they require from dedicated medical centers will not change. Therefore, the patient and the medical center need to continue to be committed to that care and the medical center cannot escape the commitment they need to provide to patients living with SCD, making them ‘inescapable.’
3 Sickle Cell Disease Adult Medical Home Annual Report 2018. VCU Health. Accessed October 1, 2024.
4 Yusuf HR, et al. Emergency Department Visits Made by Patients with Sickle Cell Disease. Am J Prev Med. July 31, 2015.
5 Mann C. CMCS Informational Bulletin. Targeting Medicaid Super-Utilizers to Decrease Costs and Improve Quality. The Center for Medicaid and CHIP Services. July 24, 2013.
6 Sickle Cell Disease Adult Medical Home Annual Report 2019. VCU Health. Accessed October 1, 2024.
7 Sickle Cell Disease Adult Medical Home Annual Report 2020-2022. VCU Health. Accessed October 1, 2024.
8 Note: Other organizations may refer to these roles as community health workers. At VCU, these professionals are designated as “patient navigators.”
9 Kanter J, et al. Building access to care in adult sickle cell disease: defining models of care, essential components, and economic aspects. Blood Adv. August 25, 2020.
At Pfizer, we’re in relentless pursuit of breakthroughs that change patients’ lives. We innovate every day to make the world a healthier place.
Our unique resources allow us to do more for people. Using our global presence and scale, we’re able to make a difference in local communities and the world around us.
Pfizer supports the global healthcare community’s independent quality improvement initiatives to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies. For more information, please visit www.pfizer.com.
This report is sponsored by Pfizer, an Advisory Board member organization. Representatives of Pfizer helped select the topics and issues addressed. Advisory Board experts wrote the report, maintained final editorial approval, and conducted the underlying research independently and objectively. Advisory Board does not endorse any company, organization, product or brand mentioned herein.
To learn more, view our editorial guidelines.
This report is sponsored by Pfizer. Advisory Board experts wrote the report, maintained final editorial approval, and conducted the underlying research independently and objectively.
Learn more about Pfizer.
Create your free account to access 1 resource, including the latest research and webinars.
You have 1 free members-only resource remaining this month.
1 free members-only resources remaining
1 free members-only resources remaining
You've reached your limit of free insights
Never miss out on the latest innovative health care content tailored to you.
You've reached your limit of free insights
Never miss out on the latest innovative health care content tailored to you.
This content is available through your Curated Research partnership with Advisory Board. Click on ‘view this resource’ to read the full piece
Email ask@advisory.com to learn more
Never miss out on the latest innovative health care content tailored to you.